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ABSTRACT: Research has been conducted on the biotransformation of (8S,9R)-isocaryolan-
9-ol (4a) and (1S,2S,5R,8S)-8-methylene-1,4,4-trimethyltricyclo[6.2.1.02,5]undecan-12-ol (5a)
by the fungal phytopathogen Botrytis cinerea. The biotransformation of compound 4a yielded
compounds 6−9, while the biotransformation of compound 5a yielded compounds 10−13.
The activity of compounds 4a and 5a against B. cinerea has been evaluated. (8R,9R)-
Isocaryolane-8,9-diol (6), a major metabolite of compound 4a, shows activity compared to its
parent compound 4a, which is inactive. The effect of isocaryolanes 3, 4a, and 5a, together with
their biotransformation products 6−8, 10, and 14−17, on the germination and radicle and
shoot growth of Lactuca sativa (lettuce) has also been determined. Compounds 7−13 are
described for the first time.
■ INTRODUCTION
Plant pathogens such as Botrytis cinerea are responsible for
serious economic losses.1 There is a considerable need to
develop fungicides with novel modes of action to combat
resistant strains of organisms,2 lower persistence,3 reduced
toxicity4 and phytotoxicity,5 and specific rather than nonspecific
antifungal activity.6 These novel agents must be compatible
with biological crop protection agents and avoid harmful effects
on crops, workers, end consumers, and the environment.7
In phytopathogenic species, some metabolites play crucial
roles in interactions with host plants.8 Part of the interaction of
B. cinerea with host plants involves the effect that botrydial, a
nonspecific low molecular weight phytotoxin, has on the plant.9
Botrydial induces a hypersensitive response, and its toxicity is
modulated by host signaling pathways mediated by salicylic acid
and jasmonic acid. Botrydial appears to have an effector role
that allows B. cinerea to manipulate host defenses, promoting
cell death and thus enabling it to feed on necrotic tissue.10
Symptoms of the disease can be decreased by inhibiting the
production of this phytotoxin.11 Our research group has
explored a method of fungal control using nonphytotoxic
analogues of botrydial and related metabolites such as
dihydrobotrydial12 or analogues of biosynthetic intermedi-
ates9,13 (such as 1) en route to botrydial. Sesquiterpene
derivatives with several carbon skeletons have been prepared
for this purpose.14−24
Fungi are able to detoxify both synthetic and naturally
occurring antifungal compounds. B. cinerea is able to transform
plant defense compounds from active forms to inactive25 or to
detoxify antifungal compounds such as those produced by fungi
of the Tricoderma species.26 Furthermore, fungal metabolism
can activate nontoxic compounds.27 Therefore, the metabolism
of antifungal compounds should be examined to shed some
light on the mechanism of action of active compounds. Work
has been carried out on the metabolism by B. cinerea of a
number of sesquiterpenes,14−17,20−24 many of which are active
against this fungus.
Isocaryolane (compounds 3, 4, 6) and (1S,2S,5R,8R)-1,4,4,8-
tetramethyltricyclo[6.2.1.02.5]undecane (compound 5) deriva-
tives have a similar structure to that of the biosynthetic
precursors of the phytotoxin botrydial. They have been
obtained by cyclization and rearrangement of (−)-trans-
caryophyllene and caryophyllene oxide with several electro-
philic reagents, by means of a caryophylladiene intermediate
(2) (Scheme 1).28 Separate treatment of 4 and 5 with NaBH4
in MeOH leads to the more stable alcohols 4a29 and 5a,28
respectively.
We have recently described the activity and metabolism of
isocaryolane derivatives 3 and 6 by the phytopathogenic fungus
B. cinerea. The growth inhibition activity of reported
isocaryolanes on B. cinerea seems to be correlated with the
presence of an alkoxy group at C-8 and the hydroxylation
level.24 Therefore, the evaluation of the activity and metabolism
of (8S,9R)-isocaryolan-9-ol (4a) and (1S,2S,5R,8S)-8-methyl-
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ene-1,4,4-trimethyltricyclo[6.2.1.02,5]undecan-12-ol (5a) by B.
cinerea, together with previously reported data for compounds 3
and 6 and their metabolites, should clarify structure−activity
relationships for this class of compounds and provide data on
the way the fungus metabolizes the above-mentioned
compounds. This, in turn, would help to develop these
compounds as antifungal agent leads.
Fungal phytotoxins exhibit different levels and patterns of
oxidation that apparently originate from the metabolism of less
functionalized precursors.30 In B. cinerea, oxido-reductive and
degradative reactions on botrydial and related metabolites seem
to be related to a self-protection mechanism since botrydial is
toxic to the fungus itself.31 Therefore, analogues of botrydial
and its biosynthetic precursors may undergo oxidative
metabolism, which may modify not only their antifungal
properties but also their phytotoxicity. Therefore evaluation of
the phytotoxicity of compounds 3, 4a, 5a, and 6 and their
metabolites is needed in order to unravel the structure−activity
relationships of these compounds and their potential activity in
planta.
In this paper we report the metabolism by the fungus B.
cinerea of (8S,9R)-isocaryolan-9-ol (4a) and (1S,2S,5R,8S)-8-
methylene-1,4,4-trimethyltricyclo[6.2.1.02,5]undecan-12-ol
(5a), the evaluation of their activity against B. cinerea, and the
phytotoxic activity of 3, 4a, 5a, and 6 and some of their fungal
metabolites on the germination of seeds and the growth of
radicals and shoots of Lactuca sativa (lettuce).32
■ RESULTS AND DISCUSSION
The chemical transformations carried out for the preparation of
(8S,9R)-isocaryolan-9-ol (4a) and (1S,2S,5R,8S)-8-methylene-
1,4,4-trimethyltricyclo[6.2.1.02,5]undecan-12-ol (5a) are sum-
marized in Scheme 1. Compounds 4a and 5a are obtained by
treatment of (8R,9R)-isocaryolan-9-one (4) and (1S,2S,5R,8S)-
8-methylene-1,4,4-trimethyltricyclo[6.2.1.02,5]undecane-8-car-
baldehyde (5), respectively, with NaBH4 in MeOH. In turn,
compounds 4 and 5 are obtained, together with (8R,9R)-8-
methoxyisocaryolan-9-ol (3), from (1R,5R,9S)-caryophylla-4-
(12),8(13)-dien-5-ol (2) by treatment with tetracyanoethylene
(TCNE) in methanol.28 Compound 5 was obtained by
treatment of caryophyllene oxide with LiBr and TCNE, in
acetone.33
Compounds (8S , 9R)- i socaryolan-9-o l (4a) and
(1S,2S,5R,8S)-8-methylene-1,4,4-trimethyltricyclo[6.2.1.02,5]-
undecan-12-ol (5a) were each incubated separately with B.
cinerea for 5 or 9 days. A certain amount of the characteristic
metabolite of B. cinerea, dihydrobotrydial, was obtained in every
culture. The metabolites isolated (Scheme 2) were tabulated
(see Table 1) and quantified for each culture (see Experimental
Section). The metabolites were identified by their 1H (see
Table 2) and 13C (see Table 3) NMR spectra, combined with
1D and 2D NMR techniques and by comparison with authentic
samples, where appropriate.
The biotransformation of (8S,9R)-isocaryolan-9-ol (4a) led
to the isolation of five products. Compounds 7 and 8 displayed
similar signal patterns in their 13C NMR spectra (Table 3).
Compound 7 showed an HREIMS molecular ion peak at m/z
236.1779, consistent with the molecular formula C15H24O2. Its
IR spectrum showed absorptions at 3454 and 1695 cm−1,
indicating the presence of hydroxyl and carbonyl functions,
corroborated by carbon resonances at δC 71.9 ppm and 215.6
Scheme 1
Scheme 2
Table 1. Metabolites of Isocaryolane Derivatives Produced
by B. cinerea
substrate metabolitesa
4a DHB, 6, 7, 8, 9
5a DHB, 10, 11, 12, 13
aDHB = dihydrobotrydial.
Journal of Natural Products Article
dx.doi.org/10.1021/np3009013 | J. Nat. Prod. 2013, 76, 1016−10241017
ppm. Compound 8 showed an HREIMS molecular ion peak at
m/z 238.1976, consistent with the molecular formula
C15H26O2. An IR spectrum showing a broad band absorption
at 3230 cm−1 and 13C NMR signals at δC 72.4 and 73.1 ppm
suggested the presence of two hydroxyl groups in the molecule.
HMBC correlations of carbon resonances at δC 215.6 and
73.1 ppm for compounds 7 and 8, respectively, are consistent
with the assignment of these resonances to carbon C-9 in each
compound (quaternary carbon for 7 and methyne for 8). 13C
NMR resonances at δC 71.9 and 72.4 ppm for compounds 7
Table 2. 1H NMR Spectroscopic Data for 7−13
7 8 9 10 11 12 13
position δH
b (mult, J in Hz)
δH
b (mult, J in
Hz)
δH
a (mult, J in
Hz)
δH
a (mult, J in
Hz)
δH
a (mult, J in
Hz) δH
a (mult, J in Hz) δH
b (mult, J in Hz)
1
2 α: 1.76−1.60 (m) α: 2.21 ddd (12.0,
10.4, 8.0)
α: 1.85, dd (12.6,
8.7)




α: 1.86, dt (11.4, 11.4,
7.8)
α: 1.74 (m)
3 a: 1.76−1.60 (m) a,b: 1.46−1.38 β: 3.41, d (8.7) α: 1.53, dd (9.6,
8.1)
a: 1.57−1.50 (m) a: 1.40−1.35 (m) α: 1.70 (m)
b: 1.43 (m) β: 1.33 (m) b: 1.34 (m) b: 1.51−1.45 (m) β: 1.33 (m)
4
5 β: 1.85 ddd (11.2,
10.4, 3.4)
β: 1.89 dt (12.0,
6.8)
β: 1.20 (m) β: 1.66−1.63 (m) β: 1.69, t (10.5) β: 1.78, t (11.4) β: 1.78 (m)




α: 3.69, ddd (11.4,
9.6, 6.0)
a: 1.83 (m)
b: 1.41 (m) b: 1.46 (m)
7 a: 2.27 dddd (12.4,
5.3, 5.2, 4.6)
a: 1.74−1.66 (m) a: 1.83−1.75 (m) α: 1.91, dd (12.6,
6.0)
α: 2.20, dd (12.6,
5.7)
α: 1.97, dd (13.2, 6.0) a: 1.44 (m)
b: 1.19 (m) b: 1.46−1.38 (m) b: 1.36 (m) β: 1.18, dd (12.6,
9.9)
β: 0.86, dd (12.6,
10.2)
β: 1.26−1.23 (m) b: 1.28 (m)
8 2.53−2.48 (m) 2.12 (m) 2.13 (m)




a,b: 1.47−1.43 α: 4.16, dd (9.3,
6.9)
a: 1.51−1.45 (m) b:
1.26−1.23 (m)
a: 1.52−1.43 (m) b:
1.38 (m)
10 a: 2.48−2.37(m) a: 1.80 (m) a: 1.83−1.75 (m) a,b: 1.37−1.31 α: 1.93 (m) 1.40−1.35 (m) a,b: 1.42−1.35
b: 1.76−1.60 (m) b: 1.74−1.66 (m) b: 1.67 (m) β: 1.36, dd (11.4,
9.3)
11 a: 2.53−2.37 (m) a: 1.46−1.38 (m) a: 1.27, td (13.2,
4.2)
a: 1.05, d (12.6) a,b: 1.57−1.50 a: 1.08, d (12.6) a: 1.62, d (12.4)
b: 1.76−1.60 (m) b: 1.21 dt (13.2,
4.4)
b: 1.49 (m) b: 1.66−1.63 (m) b:1.67, dd (12.6, 2.4) b: 1.08, d (12.4)
12 a: 2.05−2.01 (m) a: 1.74−1.66 (m) a: 1.69−1.59 (m) 3.33 (s) a: 3.55, d (11.4) a,b: 3.38 (s) 3.32 (s)
b: 1.76−1.61 (m) b: 1.05, dd (14.4,
4.8)
b: 1.09 dd (13.8,
4.8)
b: 3.46, d (11.4)
13 0.89 (s) 0.76 (s) 0.91 (s) 0.93 (s) 0.92 (s) 0.91 (s) 0.92 (s)
14α 0.97 (s) 1.04 (s) 0.91 (s) 1.14 (s) 1.12 (s) 1.21 (s) a: 4.02, d (11.2) b:
3.90, d (11.2)
15β a,b: 3.33 (s) a,b: 3.34 (s) 1.01 (s) 1.10 (s) 1.09 (s) a: 3.43, d (9.3) a: 3.71, d (10.4)
b: 3.32, d (9.3) b: 3.66, d (10.4)
aAcquired in CDCl3 (600 MHz).
bAcquired in CDCl3 (400 MHz).
Table 3. 13C NMR Spectroscopic Data (CDCl3, 100 MHz) for Compounds 4a, 5a, and 7−13
4a29 5a28 7 8 9 10 11 12 13




a mult. δC, mult.
1 31.4, C 33.3, C 31.9, C 31.6, C 30.9, C 41.0, C 37.6, C 41.1, C 41.2, C
2 38.3, CH 46.1, CH 42.1, CH 39.3, CH 52.3, CH 41.6, CH 42.1, CH 42.1, CH 46.8, CH
3 36.0, CH2 37.2, CH2 30.3, CH2 30.8, CH2 75.8, CH 36.5, CH2 36.5, CH2 32.2, CH2 28.8, CH2
4 34.3, C 41.1 C 37.8, C 39.1, C 40.2, C 33.3, C 33.3, C 38.7, C 42.5, C
5 46.1, CH 49.1 CH 40.7, CH 40.8, CH 38.5, CH 53.9, CH 54.2, CH 52.6, CH 45.2, CH
6 24.2, CH2 34.0, CH2 26.0, CH2 24.4, CH2 23.9, CH2 72.5, CH 72.0, CH 70.0, CH 27.0, CH2
7 24.3, CH2 28.5, CH2 29.5, CH2 24.2, CH2 24.9, CH2 44.8, CH2 44.2, CH2 43.9, CH2 34.1, CH2
8 39.5, CH 47.5, C 44.7, CH 38.2, C 38.3, C 45.9, C 48.0, C 46.7, C 47.5, C
9 73.1, CH 25.7, CH2 215.6, C 73.1, CH 72.8, CH 28.9, CH2 77.1, CH 29.8, CH2 28.5, CH2
10 27.9 CH2 45.2, CH2 36.5, CH2 27.7, CH2 28.2, CH2 44.8, CH2 55.6, CH2 44.8, CH2 45.1, CH2
11 38.4 CH2 47.8, CH2 36.6, CH2 38.2, CH2 39.7, CH2 47.3, CH2 44.9, CH2 47.5, CH2 47.6, CH2
12 40.2 CH2 73.7, CH2 41.9, CH2 40.2, CH2 40.5, CH2 73.4, CH2 68.8, CH2 73.4, CH2 73.6, CH2
13 26.4, CH3 30.5, CH3 25.8, CH3 26.3, CH3 25.7, CH3 22.3, CH3 22.4, CH3 22.2, CH3 22.1, CH3
14 20.6, CH3 22.3, CH3 17.1, CH3 16.0, CH3 14.7, CH3 20.6, CH3 20.4, CH3 15.8, CH3 65.9, CH2
15 30.6, CH3 20.4, CH3 71.9, CH2 72.4, CH2 28.2, CH3 31.9, CH3 31.8, CH3 73.4, CH2 73.2, CH2
a150 MHz.
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and 8, respectively, are assigned to methylene groups that show
HMBC correlations with H-3a, H-5β, and H3-14 for 7 and H-
3a,b and H3-14 for 8. These observations are consistent with
the assignment of these carbon resonances to C-15 in each
compound. Further confirmation of these assignments is
supported by NOESY correlations among H2-15 and H-5β
and H3-14 in both 7 and 8. On this basis, the structures of these
metabolites were determined as (4R,8S)-15-hydroxyisocaryo-
lan-9-one (7) and (4R,8S,9R)-isocaryolane-9,15-diol (8),
respectively.
Compound 9 presented an HREIMS molecular ion peak at
m/z 238.1027, consistent with the formula C15H26O2, and an
IR absorption band at 3362 cm−1, which reveals the presence of
two hydroxyl groups. One of them is located at C-9 (δC 72.8
ppm), as in the starting material. The corresponding H-9β
showed COSY correlations with hydrogens on C-10. The
second oxygenated function was found to be located at C-3. On
one hand, in the COSY experiment, the signal at δH 3.41 ppm, a
doublet, was correlated with H-2α. On the other hand, NOESY
experiment correlations between this signal and H-5β and
methyl groups CH3-13 and CH3-15 were consistent with α
stereochemistry for the OH group. Therefore, this metabolite
was assigned as (3S,8S,9R)-isocaryolane-3,9-diol (9).
Finally, (8R,9R)-isocaryolane-8,9-diol (6), identified by
comparison with authentic samples and its spectroscopic
data,28 was also isolated as a metabolite of (8S,9R)-
isocaryolan-9-ol (4a).
F e ed i n g o f (1S , 2S , 5R , 8S ) - 8 -me th y l en e - 1 , 4 , 4 -
trimethyltricyclo[6.2.1.02,5]undecan-12-ol (5a) yielded com-
pound 10 as the major metabolite after 5 (4% yield) and 9
(10% yield) days of incubation. Its HREIMS exhibited a
molecular ion peak at m/z 238.1933 consistent with the
formula C15H26O2. Resonances in the
13C NMR spectrum of
compound 10 at δC 73.4 and 72.5 ppm indicated two
oxygenated functions in the molecule, the first related to the
C-12 methylene alcohol of the starting material and the second
to a hydroxylated methyne carbon, according to DEPT. This
carbon was assigned to C-6 owing to a downfield displacement
of C-5 and C-7 resonances from δC 46.1 and 24.3 ppm,
respectively, in the starting material28 to δC 53.9 and 44.8 ppm,
respectively, in 10. The 1H NMR spectrum showed a signal at
δH 3.78 ppm, which was assigned to H-6α. COSY correlations
between the signals of H-6 and H-5β (δH 1.66−1.63), H-7α (δH
1.18), and H-7β (δH 1.91) were observed. The stereochemistry
of the hydroxyl group at C-6 as β-OH has been confirmed by
NOESY data on the basis of correlations observed between the
H-6 signal (δH 3.78) and the methyl group H3-14 (δH 1.14) and
H-7α (δH 1.91) and between the latter and H2-12 (δH 3.33).
Signal assignments at δH 1.14 as H3-14 and δH 1.10 as H3-15 are
supported by NOESY effects with H-2α and H3-5β signals,
respectively (see Figure 1). These data led to the assignment of
the structure of this compound as (1S,2S,5R,6S,8S)-8-
methylene-1,4,4-trimethyltricyclo[6.2.1.02,5]undecane-6,12-diol
(10).
Compound 11 possesses three hydroxyl groups, as shown by
resonances at δC 72.0 (CH), 77.1 (CH), and 68.8 (CH2) ppm,
the latter referring to the hydroxymethylene group at C-12
already present in the starting material. The displacement of the
C-9 chemical shift (δC 25.7 ppm in the starting material and δC
77.1 ppm in 11), as well as the downfield resonances of C-8 (δC
48.0) and C-10 (δC 55.6), were indicative of a C-9
hydroxylation. COSY correlations were consistently found
between H-9 and both H-10 (δH 1.36 and 1.93 ppm). The third
hydroxyl group (δC 72.0, δH 3.76 ppm) was located at C-6, as in
compound 10, due to the downfield shifts of C-5 and C-7 and
to the COSY correlations between the H-6 signal at δH 3.76
ppm and the resonances of H-7α (δH 2.20 ppm), H-7β (δH
0.86 ppm), and H-5β (δH 1.69 ppm). The stereochemistry of
the C-6 and C-9 hydroxyl groups was determined as β based on
a series of NOESY correlations observed between H-6α, CH3-
14, and H-9α and between H-9α, H-6α, and H-2α. Lastly, the
assignment of H3-14 as a signal at δH 1.12 is supported by
NOESY effects between this methyl and H-2α and H-6α (see
Figure 2). This compound was therefore assigned as
(1R,2S,5R,6S,8R,9S)-8-methylene-1,4,4-trimethyltricyclo-
[6.2.1.02,5]undecane-6,9,12-triol (11).
Compound 12 presented an HREIMS molecular ion peak at
m/z 254.1886, consistent with the formula C15H26O3, which
indicates a trihydroxylated derivative. Its 13C NMR spectrum
featured one methine hydroxylated carbon (δC 70.0 ppm) and
two hydroxyl-methylene groups (both at δC 73.4 ppm). As with
the previous assignments, two of the hydroxyl groups were
located at C-12 (δC 73.4 ppm) (from the starting material) and
at C-6 (δC 70.0 ppm; δH 3.69 ppm, H-6α). COSY correlations
between H-6α and H-5β (δH 1.78 ppm) and between H-7α (δH
1.97 ppm) and H-7β (δH 1.26−1.23 ppm), as well as NOESY
interactions between H-6α and CH3-14α (δH 1.21 ppm), H-7α
(δH 1.97 ppm), and H-2α (δH 1.86 ppm), were fully consistent
with this assignment (Figure 3). These NOESY interactions,
together with those observed between CH3-14α and CHH-15a
(δH 3.43 ppm) and CHH-15b (δH 3.32 ppm), on one hand,
and between CHH-15b (δH 3.32 ppm) and H-5β (δH 1.78
ppm) on the other, allowed the assignment of the remaining
hydroxylation point at CH2-15β. These data confirmed the
structure of this metabolite as (1S,2S,4R,5R,6S,8S)-1,4-
dimethyl-4,8-dimethylenetricyclo[6.2.1.02,5]undecane-6,12,15-
triol (12).
Compound 13 showed an HREIMS molecular ion peak at
254.1880, also consistent with the formula C15H26O3. Analysis
Figure 1. Selected NOESY enhancements for compound 10.
Figure 2. Selected NOESY enhancements for compound 11.
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of its 13C NMR spectrum confirmed the presence of three
hydroxymethylene groups at δC 65.9, 73.2, and 73.6 ppm,
respectively. Analysis of 2D-NMR data suggested that both
methyls on the gem-dimethyl group at 5a had undergone
hydroxylation. HMBC correlations among oxygen-substituted
methylene signals at δC 65.9 ppm and signals at δH 1.70 (H-3α)
and 1.33 (H-3β) and NOESY correlations of signals at δH 4.02
(CHH-14a) and 3.90 (CHH-14b) with those at δH 1.74 (H-
2α) and 1.70 (H-3α), support the assignment of the
hydroxymethylene group as CH2-14α. Furthermore, HMBC
correlations between the signals at δC 73.2 ppm (C-15) and
those at δH 1.70 (H-3α) and 1.33 (H-3β) and NOESY
correlations between signals at δH 3.71, 3.66 (H2-15a,b), 1.78
(H-5β), and 1.33 (H-3β) led to the assignment of this
hydroxymethylene group as CH2-15β. The spectroscopic data
support the proposed structure of this product as
(1S,2S,5R,8S)-1-methyl-4,4,8-trimethylenetricyclo[6.2.1.02,5]-
undecane-12,14,15-triol (13).
As described above, incubation of isocaryolane derivatives
(8S,9R)-isocaryolan-9-ol (4a) and (1S,2S,5R,8S)-8-methylene-
1,4,4-trimethyltricyclo[6.2.1.02,5]undecan-12-ol (5a) with B.
cinerea yielded compounds derived from oxidation of
inactivated saturated positions, including the bridge-head
position C-8 (compound 6, 15% from 4a). This compound is
also obtained from the biotransformation of (8R,9R)-8-
methoxyisocaryolan-9-ol (3) through ether cleavage on the
methoxy substituent, as described previously (compound 6,
from 3, 25% yield, 5 days feeding).24
Furthermore, further oxidation at position C-12 of
metabolites of 5a is not observed, and there is only one
metabolite derived from 4a, where C-9 shows further oxidation
(compound 7). This suggests that the hydroxyl group at these
positions may be interacting with a binding site in the
enzymatic complex responsible for hydroxylations. Occurrence
of compound 7 may be explained by further oxidation of
compound 8, where binding on the enzymatic complex would
take place at the hydroxyl group on C-15.
The antifungal properties of compounds 4a and 5a were
determined against the growth of B. cinerea using the poisoned
food technique34 and compared with the previously reported
activity for compounds 3, 6, and (4R,8R,9R)-8-methoxyisocar-
yolane-9,15-diol (14), a metabolite of 3.24 The commercial
fungicide Euparen (dichlofluanid) was used as a standard for
comparison in this test. Several levels of inhibition were
observed (Figure 4). Compound 5a showed inhibition levels
similar to those reported for compounds 3 and 6. Compound
4a showed a lower activity level comparable to that reported for
compound 14.24
Therefore, the presence of an oxygen-bearing functional
group at C-8 is essential for the antifungal activity of
isocaryolane derivatives. Compound 5a, more persistent than
compound 4a, 3, or 6,35 bears a CH2OH moiety at an
equivalent position and maintains a similar activity to that of
diol 6.
The effect of previously reported (8R,9R)-8-methoxyisocar-
yolan-9-ol (3) and (8R,9R)-isocaryolane-8,9-diol (6), their
metabolites 14, (4R,8R,9R)-isocaryolane-8,9,15-triol (15),
(3S,8R,9R)-isocaryolane-3,8,9-triol (16), and (6R,8S,9R)-iso-
caryolane-6,8,9-triol (17),24 starting materials 4a and 5a, and
biotransformation products 6−8 and 10 on germination
(Figure 5) and radicle and shoot growth (Figure 6) of L.
sativa (lettuce) was evaluated. L. sativa seeds have proven to be
suitable for use in bioassays to evaluate phytotoxicity,
specifically focusing on allelochemical detection, because they
Figure 3. Selected NOESY enhancements for compound 12.
Figure 4. Comparison of fungal growth inhibition (B. cinerea) among
compounds 3, 4a, 5a, 6, and 14 (100 ppm dose; 3 (0.40 × 10−3 M),
4a, 5a (0.45 × 10−3 M), 6 (0.42 × 10−3 M), and 14 (0.37 × 10−3 M)).
Figure 5. Effect of isocaryolane derivatives 3, 4a, 5a, 6−8, 10, and 14−
17 on germination of L. sativa (see biotransformation compounds in
Table 1). Values are presented as percentage differences from the
control: zero representing an observed value identical to the control, a
positive value representing stimulation, and a negative value
representing inhibition.
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are readily available and are characterized by swift, complete,
and uniform germination.32c
Predominance of germination inhibitory effect was observed
at the higher concentration used (10−3 M). Compound 3
exhibited a consistent inhibitory effect on germination for all
the concentrations evaluated, somewhat higher at 10−3 M (ca.
25%) (Figure 5). Compounds 14, 15, and 16 inhibited
germination at 10−3 and 10−5 M, while compound 17 exhibited
a stimulatory effect at all the concentrations evaluated.
Isocaryolane skeleton compounds 4a and 6 and
tetramethyltricyclo[6.2.1.02,5]undecane skeleton derivative 5a
have a similar effect on germination at the 10−3 M level, while
(8R,9R)-8-methoxyisocaryolan-9-ol (3) showed higher inhib-
ition at the 10−3 M level. On the other hand, biotransformation
derivatives 7 and 8 showed decreased inhibitory levels (Figure
3).
Interestingly, compound 5a and its biotransformation
derivative 10 exhibited opposite effects: whereas the starting
material 5a inhibited germination (at 10−3 M), metabolite 10,
containing a further hydroxylation at C-6 in relation to 5a,
showed a slight stimulatory effect at all tested concentrations
(Figure 5).
Postgermination effects were generally greater than those
observed for germination. Regarding radicle and shoot growth,
the tested compounds generally had the opposite effect, i.e.,
stimulation of radicle growth and inhibition of shoot growth,
with the exception of compound 6, which inhibited the growth
of both shoots and radicles.
Compounds 3, 4a, 5a, 6, and 8 inhibited L. sativa shoot
growth, this effect being concentration dependent. Biotransfor-
mation products 7, 10, 14, 15, 16, and 17 showed similarly
lower inhibitory effects at concentrations of 10−3 M. A clear
pattern could not be drawn from observations at lower
concentrations (Figure 6).
A greater inhibition effect on root growth was observed for 6
at 10−3 M, and 4a had the highest stimulatory effect on root
growth at 10−3 M. Behavior at lower concentrations was more
erratic but generally had a mild stimulatory effect.
If we compare the fungal growth inhibition assay and the
phytotoxicity data, compounds 3 and 4a, along with their main
metabolites 6, 7, and 14, are moderately phytotoxic to L. sativa
at a concentration (10−3 M) comparable to that tested against
B. cinerea (0.37 × 10−3 to 0.42 × 10−3 M range; see Figure 4);
in any case, their phytotoxicity decreases sharply at lower
concentrations, i.e., at a natural concentration for biotransfor-
mation compounds. Therefore, the metabolism of isocaryolane
skeleton compounds by B. cinerea probably does not increase
phytotoxicity. Compound 5a has greater phytotoxicity potential
and was the strongest inhibitor of shoot development, reducing
growth by nearly 50% at 10−3 M, and it is not as readily
metabolized by the fungus as compounds 3, 4a, and 6.35 On the
other hand, compound 5a managed to promote only a modest
increase in radicle growth at 10−3 M, and its main metabolite
(compound 10) is not phytotoxic.
In conclusion, the biotransformation of (8S,9R)-isocaryolan-
9 -o l (4a) and (1S , 2S , 5R , 8S) -8 -methy lene -1 ,4 ,4 -
trimethyltricyclo[6.2.1.02,5]undecan-12-ol (5a) by B. cinerea
produced a series of hydroxylated compounds with different
levels of phytotoxicity against L. sativa and growth inhibition of
B. cinerea. Compound 4a was hydroxylated at C-3 (α position),
C-6 (α position), and C-8 and C-15 (compounds 6−9), while
compound 5a was hydroxylated at C-6 (β position), C-9 (β
position), and C-14 and C-15 (compounds 10−13). These
hydroxylation patterns are consistent with those previously
described in the biotransformation of (8R,9R)-8-methoxyiso-
caryolan-9-ol (3) and (8R,9R)-isocaryolane-8,9-diol (6).24
Compound 6, also a B. cinerea metabolite of (8S,9R)-
isocaryolan-9-ol (4a), shows activity compared to its parent
compound 4a, which is inactive. Therefore, the presence of an
oxygenated function at C-8 is essential for antifungal activity on
isocaryolane derivatives.
Compounds 4a and 5a and their main metabolites exhibit a
moderate phytotoxic effect on L. sativa but with little effect at
concentrations found naturally for biotransformation com-
Figure 6. Effect of isocaryolane derivatives 3, 4a, 5a, 6−8, 10, and 14−
17 on L. sativa radicle and shoot length (see biotransformation
compounds in Table 1). Values are presented as percentage differences
from the control: zero representing an observed value identical to the
control, a positive value representing stimulation, and a negative value
representing inhibition.
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pounds. Therefore, active isocaryolane derivatives are models of
antifungal agents against B. cinerea, whose phytotoxicity against
L. sativa is not enhanced by metabolism by the fungus.
■ EXPERIMENTAL SECTION
General Experimental Procedures. Melting points were
measured with a Reichert-Jung Kofler block and are uncorrected.
Optical rotations were determined on a Perkin-Elmer 341 polarimeter.
IR spectra were recorded on a Perkin-Elmer Spectrum BX FT-IR
spectrophotometer. 1H and 13C NMR spectra were obtained on Varian
INOVA 400 and INOVA 600 NMR spectrometers using tetrame-
thylsilane as an internal reference. NMR assignments were made by a
combination of 1D and 2D techniques and by comparison with
assignments available in the literature for previously described
compounds, where appropriate. Mass spectra were recorded on a
Finnigan Voyager spectrometer at 70 eV. High-resolution mass spectra
were recorded on a Micromass Autospec spectrometer at 70 eV.
HPLC was performed with a Hitachi/Merck L-6270 apparatus
equipped with a UV−vis detector (L 4250) and a differential
refractometer detector (RI-71). TLC was performed on Merck
Kiesegel 60 F254, 0.2 mm thick. Silica gel (Merck) was used for
column chromatography. Purification by HPLC was performed using a
Si gel column (LiChrospher Si 60, 10 μm, 1 cm wide, 25 cm long).
Microorganism and Antifungal Assays. The culture of Botrytis
cinerea strain UCA 992 employed in this work was isolated from
Domecq vineyard grapes, Jerez de la Frontera, Cad́iz, Spain. This
culture of B. cinerea has been deposited at the Mycological Herbarium
Collection (UCA), Facultad de Ciencias, Universidad de Cad́iz.
Antifungal bioassays were performed by measuring radial growth on
agar medium in a Petri dish in the presence of test compounds. Test
compounds were dissolved in EtOH to a final compound
concentration in the culture medium of 50 to 200 mg L−1. Solutions
of test compounds were added to glucose-malt-peptone-agar medium
(61 g of glucose-malt-peptone-agar per L, pH 6.5−7.0). The final
EtOH concentration was identical in both the control and treated
cultures. The medium was poured in 6 or 9 cm diameter sterile plastic
Petri dishes, and a 5 mm diameter mycelia disk of B. cinerea cut from
an actively growing culture was placed in the center of the agar plate.
Radial growth was measured for six days. Every concentration was
evaluated in triplicate.
General Culture Conditions. B. cinerea (UCA 992) was grown on
a Czapek-Dox medium composed of (per L of distilled water), glucose
(40 g), yeast extract (1 g), potassium dihydrogen phosphate (5 g),
sodium nitrate (2 g), magnesium sulfate (0.5 g), ferrous sulfate (10
mg), and zinc sulfate (5 mg) in surface and shaking conditions. Surface
culturing was carried out in Roux bottles (150 mL per flask), and
shaken experiments were conducted using conical flasks (200 mL per
flask). In both cases, growth was carried out at 25 °C for 4 days, and
then the substrate, dissolved in ethanol, was added to each flask.
Incubation lasted 5 or 9 days, after which the mycelium was filtered
and washed with brine and EtOAc. The broth was saturated with
sodium chloride, acidified (pH 2), and extracted with EtOAc. The
extracts were separated into acidic and neutral fractions with aqueous
sodium bicarbonate. The acid fraction was recovered in EtOAc. The
extracts were dried over sodium sulfate, the solvent was evaporated,
and the residues were chromatographed using silica gel and a gradient
mixture of petroleum ether−EtOAc of increasing polarity. The acidic
fractions were methylated with diazomethane prior to chromatog-
raphy. Chromatography of the acidic fractions yielded inseparable
mixtures.
Biotransformation of (8S,9R)-Isocaryolan-9-ol (4a) by B.
cinerea. Compound 4a (300 mg) was distributed in 20 flasks.
Cultures were grown in shaken conical flasks for 5 and 9 days.
Chromatography of the neutral fraction (5 days, 10 flasks) gave 4a (40
mg), 6 (19 mg), 7 (3 mg), 8 (3 mg), 9 (2 mg), and dihydrobotrydial
(4 mg). Chromatography of the neutral fraction (9 days, 10 flasks)
gave 4a (34 mg), 6 (10 mg), 7 (3 mg), 8 (6 mg), 9 (4 mg), and
dihydrobotrydial (13 mg).
Biotransformation of (1S,2S,5R,8S)-8-Methylene-1,4,4-
trimethyltricyclo[6.2.1.02,5]undecan-12-ol (5a) by B. cinerea.
Compound 5a (330 mg) was distributed in 22 Roux bottles. Cultures
were grown for 5 and 9 days. Chromatography of the neutral fraction
(5 days, 11 flasks) gave 5a (78 mg), 10 (7 mg), 11 (<1 mg), 12 (<1
mg), 13 (1 mg), and dihydrobotrydial (17 mg). Chromatography of
the neutral fraction (9 days, 11 flasks) gave 5a (24 mg), 10 (18 mg),
11 (1 mg), 12 (<1 mg), 13 (1 mg), and dihydrobotrydial (41 mg).
Bioassay for Germination and Growth of Lettuce Seeds.
Lactuca sativa (cv. Grand Rapids) seeds were purchased from Isla Pak,
RS, Brazil. All undersized and damaged seeds were discarded. The
bioassay was conducted in 100 mm Petri dishes containing Whatman
#1 filter paper (90 mm) as a support. L. sativa seeds (25 per dish),
controls, and test compound solutions (10 mL) at concentrations of
10−3, 10−5, and 10−7 M were placed on the dishes. All solutions were
prepared with deionized water, and the pH values, buffered with 10
mM 2-(N-morpholino)ethanesulfonic acid (MES), were adjusted to
6.0−6.5 with NaOH solution. Concentrations lower than 10−3 M were
obtained by serial dilution. Dishes were wrapped with Parafilm to
reduce evaporation and incubated in the dark at 25 °C in an
environmental chamber. After 5 days, germinated seeds were counted
(a seed was considered to be germinated when the radicle was at least
0.2 mm long) and the lengths of radicle and shoots were measured
using a pachymeter. Dishes were kept at 4 °C during the measurement
process to prevent subsequent growth. Osmotic pressure values were
measured on a microsmometer and ranged between 30 and 38
mOsmolar.32b The experiment was carried out in triplicate.
Data Analysis. The effects of the test compounds on L. sativa
germination and growth are given as percent differences from control,
calculated from the differences (in cm) between mean values obtained
upon addition of test compounds and mean values obtained for
control (seeds grown without addition of tested compounds)/mean
values for control × 100. Thus, zero represents the control, positive
values represent stimulation of the studied parameter, and negative
values represent inhibition. The data were evaluated using Student’s t
tests, and the differences between the experiment and control were
significant at a value of p ≤ 0.0517.
(4R,8S)-15-Hydroxyisocaryolan-9-one (7): oil; [α]25D −10 (c 0.22,
CDCl3); IR (film) νmax 3454, 2933, 1695, 1458, 1038, 517 cm
−1; 1H
NMR (CDCl3, 400 MHz), see Table 2;
13C NMR (CDCl3, 100 MHz),
see Table 3; HMBC (selected correlations) C2 → H3-13, H12a,b ; C3
→, H3-14, H2-15; C9 → H-10a,b, H-11a,b; C10 → H-8, H-11a,b; C12
→ H-3a,b, H-7a,b; C15 → H-3a, H-5β, H3-14; EIMS m/z 236 [M]
+
(5), 218 (29), 179 (17), 165 (58), 147 (66), 122 (58), 109 (82), 95
(92), 81 (100), 55 (92); HREIMS m/z 236.1779 [M]+ (calcd for
C15H24O2, 236.1776).
(4R,8S,9R)-Isocaryolane-9,15-diol (8): amorphous solid; [α]25D
+22 (c 0.15, CHCl3); IR (film) νmax 3230, 2922, 1474, 1094 cm
−1;
1H NMR (CDCl3, 400 MHz), see Table 2;
13C NMR (CDCl3, 100
MHz), see Table 3; HMBC (selected correlations) C1 → H3-13, H-
3a,b ; C3 → H-5β, H3-14, H2-15; C5 → H3-14, H2-15; C7 → H-9β; C9
→ H-10a,b, H-11a,b; C14 → H-5β, H2-15, H-3a,b; C15 → H3-14, H-
3a,b; EIMS m/z 238 [M]+ (8), 220 (31), 175 (32), 149 (34), 118
(36), 109 (41), 82 (100), 81 (49), 41 (41); HREIMS m/z 238.1976
[M]+ (calcd for C15H26O2, 238.1933).
(3S,8S,9R)-Isocaryolane-3,9-diol (9): oil; [α]25D +6 (c 0.43,
CHCl3); IR (film) νmax 3362, 2937, 1458,1054, 756 cm
−1; 1H NMR
(CDCl3, 600 MHz), see Table 2;
13C NMR (CDCl3, 100 MHz), see
Table 3; HMBC (selected correlations) C1 → H-3α, H-5β; C2 → H3-
13, H-11a,b, H-6b, H-12a,b; C3 → H-5β, H3-14, H3-15; C6 → H-2α,
H-8; C7 → H-12a,b, H-9β; C9 → H-7a,b, H-12ab; C10 → H-8; C14 →
H-5β, H3-15; EIMS m/z 238 [M]
+ (4), 220 (18), 193 (35), 174 (23),
148 (33), 135 (25), 107 (42), 93 (53), 82 (100), 72 (60), 69 (51), 41
(43); HREIMS m/z 238.1027 [M]+ (calcd for C15H26O2, 238.1933).
(1S,2S,5R,6S,8S)-8-Methylene-1,4,4-trimethyltricyclo[6.2.1.02,5]-
undecane-6,12-diol (10): yellow oil; [α]25D +9 (c 0.46, CDCl3); IR
(film) νmax 3361, 2948, 2864, 1458, 1037, 756 cm
−1; 1H NMR
(CDCl3, 600 MHz), see Table 2;
13C NMR (CDCl3, 150 MHz), see
Table 3; HMBC (selected correlations) C1 → H-9a,b; C2 → H-11a,b;
C3 → H3-14, H3-15, C5 → H-7α, H-3α, H-2α, H3-14, H3-15; C7 →,
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H2-12, H-5β, H-9a,b; C9 → H2-12, H-7α; C10 → H3-13, H-11a,b;
EIMS m/z 238 [M]+ (6), 230 (18), 220 (24), 207 (78), 168 (38), 123
(42), 118 (52), 95 (54), 81 (62), 68 (100), 43 (44); HREIMS m/z
238.1933 [M]+ (calcd for C15H26O2, 238.1933).
(1R,2S,5R,6S,8R,9S)-8-Methylene-1,4,4-trimethyltricycle-
[6.2.1.02,5]undecane-6,9,12-triol (11): oil; [α]25D +23 (c 0.12,
CDCl3); IR (film) νmax 3421, 2948, 1462, 1042, 589 cm
−1; 1H
NMR (CDCl3, 600 MHz), see Table 2;
13C NMR (CDCl3, 150 MHz),
see Table 3; HMBC (selected correlations) C2 → H3-13, H-11a,b; C3
→ H3-14, H3-15; C5 → H-3a, H3-14, H3-15, H-7α; C7 → H-5β, H-
11a,b; C10 → H-2α, H3-13; C12 → H-7α, H-7β; EIMS m/z 254 [M]
+
(0.8), 236 (6), 221 (23), 192 (35), 149 (43), 136 (60), 109 (99), 95
(86), 93 (92), 85 (100), 71 (43), 55 (70); HREIMS m/z 236.1772 [M
− 18]+ (calcd for C15H24O2, 236.1776).
(1S,2S,4R,5R,6S,8S)-1,4-Dimethyl-4,8-dimethylenetricycle-
[6.2.1.02,5]undecane-6,12,15-triol (12): oil; [α]25D +49 (c 0.14,
CDCl3); IR (film) νmax 3377, 2944, 1457, 1034, 756 cm
−1; 1H
NMR (CDCl3, 600 MHz), see Table 2;
13C NMR (CDCl3, 150 MHz),
see Table 3; HMBC (selected correlations) C1 → H-5β, H-3a, H3-13;
C5 → H-7α, H3-14, H2-15; C7 → H2-12; C9 → H2-12; C10 → H-11a,
H3-13; EIMS m/z 254 [M]
+ (5), 223 (28), 205 (26), 187 (15), 151
(35), 128 (44), 121 (43), 111 (76), 107 (93), 95 (84), 93 (100), 81
(68), 67 (29), 55 (33); HREIMS m/z 254.1886 [M]+ (calcd for
C15H26O3, 254.1882).
(1S,2S,5R,8S)-1-Methyl-4,4,8-trimethylenetricycle[6.2.1.02,5]-
undecane-12,14,15-triol (13): oil; [α]25D +32 (c 0.1, CDCl3); IR
(film) νmax 3344, 2929, 1452, 1028, 752 cm
−1; 1H NMR (CDCl3, 400
MHz), see Table 2; 13C NMR (CDCl3, 100 MHz), see Table 3;
HMBC (selected correlations) C3 → H2-14; H2-15; C5 → H2-14, H2-
15; C7 → H-11a, H2-12; C9 → H-7b, H-11a, H2-12; C13 → H-11b;
EIMS m/z 254 [M]+ (1), 223 (11), 205 (22), 187 (25), 165 (46), 135
(100), 107 (85), 93 (82), 81 (59), 67 (24), 55 (22); HREIMS m/z
254.1880 [M]+ (calcd for C15H26O3, 254.1882).
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